Jacksonville, FL, United States of America

James E Ollmann

This inventor holds 1 USPTO granted patent. Top assignee: Pcr, Inc.. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by James E Ollmann

Introduction

James E Ollmann is a notable inventor based in Jacksonville, FL (US). He has made significant contributions to the field of chemistry, particularly in the development of novel compounds. His work has led to the creation of a patent that showcases his innovative approach to chemical processes.

Latest Patents

James E Ollmann holds a patent for a process involving 2-deoxyuridines and riboside precursors. This patent outlines a method for preparing certain 2-deoxyuridines, which includes forming a substituted alkyl 5-O-'protected'-2-deoxyribofuranoside, hydrocarbylating the compound, and condensing it in the presence of a Lewis or Bronsted acid with a silyluracil to form a uridine. The patent also highlights several tritylated ribofuranosides as novel compounds.

Career Highlights

Ollmann is associated with Pcr, Inc., where he has been able to apply his expertise in chemistry to advance research and development. His work has not only contributed to the scientific community but has also paved the way for potential applications in various industries.

Collaborations

James E Ollmann has collaborated with Ralph J DePasquale, further enhancing the scope of his research and innovations. Their partnership has likely led to the development of new ideas and methodologies in their field.

Conclusion

James E Ollmann's contributions to the field of chemistry through his patent and collaborations demonstrate his commitment to innovation. His work continues to influence the development of new compounds and processes in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…